Lenvatinib Mesylate and MitoMYcin (Systemic)
Determining the interaction of Lenvatinib Mesylate and MitoMYcin (Systemic) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
Generic Name: mitomycin
Brand name: Mutamycin
Synonyms: Mitomycin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib Mesylate-Mitomycin Intravenous
- Lenvatinib Mesylate-Mitotane
- Lenvatinib Mesylate-Mitoxantrone
- Lenvatinib Mesylate-Mitoxantrone Hydrochloride
- Lenvatinib Mesylate-Mitoxantrone Injection Concentrate
- Lenvatinib Mesylate-Mitoxantrone Intravenous, Injection
- MitoMYcin (Systemic)-Lenvima
- MitoMYcin (Systemic)-Lenvima (14 MG Daily Dose)
- MitoMYcin (Systemic)-Lenvima (18 MG Daily Dose)
- MitoMYcin (Systemic)-Lenvima (20 MG Daily Dose)
- MitoMYcin (Systemic)-Lenvima (24 MG Daily Dose)
- MitoMYcin (Systemic)-Lenvima (8 MG Daily Dose)